KAM
Krensavage Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.84M | Buy |
1,024,883
+270,502
| +36% | +$1.28M | 2.56% | 14 |
|
|
2025
Q1 | $3.46M | Buy |
754,381
+375,619
| +99% | +$1.72M | 1.91% | 13 |
|
|
2024
Q4 | $1.81M | Sell |
378,762
-35,922
| -9% | -$172K | 1.07% | 11 |
|
|
2024
Q3 | $1.95M | Sell |
414,684
-247,482
| -37% | -$1.16M | 1.09% | 11 |
|
|
2024
Q2 | $3.74M | Buy |
+662,166
| New | +$3.74M | 1.72% | 12 |
|
|
2023
Q4 | – | Sell |
-360,429
| Closed | -$1.56M | – | 15 |
|
|
2023
Q3 | $1.56M | Sell |
360,429
-2,522
| -0.7% | -$10.9K | 0.57% | 11 |
|
|
2023
Q2 | $2.39M | Buy |
362,951
+1,391
| +0.4% | +$9.17K | 0.76% | 10 |
|
|
2023
Q1 | $2.46M | Buy |
361,560
+16,270
| +5% | +$110K | 0.75% | 12 |
|
|
2022
Q4 | $2.55M | Buy |
345,290
+32,991
| +11% | +$244K | 0.79% | 12 |
|
|
2022
Q3 | $3.09M | Buy |
+312,299
| New | +$3.09M | 0.98% | 13 |
|